Enrolling is only one side of the equation; wonder how many, if any, patients have dropped out? I would expect that would happen on the Rems.... side only as patients won't be getting better so why stay in the trial?
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
